CompoAtlas

Lavender Prime

Natural health product licensed in Canada

Other names
Makomora - Lavender Prime, Nashé Beauty - Lavender Prime
Licence holder
AMAI Naturals Inc.
NPN or DIN-HM
80110573
Status
Active licence
Licence date
9 June 2021
Revision date
21 September 2022
Form
Huile
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Lavandula angustifolia

Source : Sommité en fleurs (herbe)

100 %

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 yearsNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Used in aromatherapy as a carminative/antispasmodic for symptomatic relief of digestive discomfort. Used in aromatherapy as a nervine/calmative. Used in aromatherapy to help relieve colds/cough. Used in aromatherapy to help relieve headache. Used in aromatherapy to help relieve joint/muscle pain associated with sprain/strain/rheumatoid arthritis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80110573

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line